Therapy of atopic eczema

por Werfel, Thomas, Claes, Christa, Kulp, Werner, Greiner, Wolfgang, von der Schulenburg, Johann-Matthias
Publicado 2006

Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1

por Thomas, Suzanne, Kuncheria, Linta, Roulstone, Victoria, Kyula, Joan N., Mansfield, David, Bommareddy, Praveen K., Smith, Henry, Kaufman, Howard L., Harrington, Kevin J., Coffin, Robert S.
Publicado 2019

28. Acute pulmonary arterial hypertension in primary Sjögren’s syndrome with known cryptogenic organising pneumonia

por Wittner, Liora, Joy, Mareen, Ellis, Spencer
Publicado 2019

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (...

por Laher, Fatima, Moodie, Zoe, Cohen, Kristen W., Grunenberg, Nicole, Bekker, Linda-Gail, Allen, Mary, Frahm, Nicole, Yates, Nicole L., Morris, Lynn, Malahleha, Mookho, Mngadi, Kathryn, Daniels, Brodie, Innes, Craig, Saunders, Kevin, Grant, Shannon, Yu, Chenchen, Gilbert, Peter B., Phogat, Sanjay, DiazGranados, Carlos A., Koutsoukos, Marguerite, Van Der Meeren, Olivier, Bentley, Carter, Mkhize, Nonhlanhla N., Pensiero, Michael N., Mehra, Vijay L., Kublin, James G., Corey, Lawrence, Montefiori, David C., Gray, Glenda E., McElrath, M. Juliana, Tomaras, Georgia D.
Publicado 2020

Antibioprophylaxie dans le cadre d'interventions obstétricales

por van Schalkwyk, Julie, Van Eyk, Nancy
Publicado 2010

EP19 Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis: a case report

por Hum, Ryan Malcolm, Kanigicherla, Durga, Ho, Pauline
Publicado 2020

1046. Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV

por Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K, Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn, Ramgopal, Moti, McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E, Brainard, Diana M, Martin, Hal
Publicado 2020

121. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Immunogenic

por Guiñazú, Javier Ruiz, Tica, Jelena, Andrews, Charles P, Davis, Matthew G, De Smedt, Philippe, Essink, Brandon, Fogarty, Charles, Kerwin, Edward, Leroux-Roels, Isabel, Vandermeulen, Corinne, David, Marie-Pierre, Dezutter, Nancy, De Schrevel, Nathalie, Fissette, Laurence, Mesaros, Narcisa
Publicado 2020

119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated

por Tica, Jelena, Guiñazú, Javier Ruiz, Andrews, Charles P, Davis, Matthew G, Essink, Brandon, Fogarty, Charles, Kerwin, Edward, Leroux-Roels, Isabel, Steenackers, Katie, Vandermeulen, Corinne, David, Marie-Pierre, Dezutter, Nancy, Fissette, Laurence, Koch, Juliane, Mesaros, Narcisa
Publicado 2020

73. Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir

por Diaz, George, Arribas, Jose Ramon, Arribas, Jose Ramon, Robinson, Philip A, Cattelan, Anna Maria, Tashima, Karen T, Tsang, Owen Tak-Yin, Tsang, Owen Tak-Yin, Chen, Yao-Shen, Chen, Yao-Shen, SenGupta, Devi, Vendrame, Elena, Blair, Christiana, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Chin, Bum Sik, Chin, Bum Sik, Spinner, Christoph, Criner, Gerard J, Criner, Gerard J, Muñoz, Jose, Lye, David Chien Boon, Lye, David Chien Boon, Gottlieb, Robert L
Publicado 2020

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial

por Bandyopadhyay, Ananda S, Gast, Chris, Rivera, Luis, Sáez-Llorens, Xavier, Oberste, M Steven, Weldon, William C, Modlin, John, Clemens, Ralf, Costa Clemens, Sue Ann, Jimeno, Jose, Rüttimann, Ricardo
Publicado 2021

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging stu...

por Goepfert, Paul A, Fu, Bo, Chabanon, Anne-Laure, Bonaparte, Matthew I, Davis, Matthew G, Essink, Brandon J, Frank, Ian, Haney, Owen, Janosczyk, Helene, Keefer, Michael C, Koutsoukos, Marguerite, Kimmel, Murray A, Masotti, Roger, Savarino, Stephen J, Schuerman, Lode, Schwartz, Howard, Sher, Lawrence D, Smith, Jon, Tavares-Da-Silva, Fernanda, Gurunathan, Sanjay, DiazGranados, Carlos A, de Bruyn, Guy
Publicado 2021

Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19

por Vasileiou, Spyridoula, Kuvalekar, Manik, Workineh, Aster, Watanabe, Ayumi, Velazquez, Yovana, Lulla, Suhasini, Heslop, Helen E., Mooney, Kimberly, Grimes, Kevin, Carrum, George, Hill, LaQuisa C., Lulla, Premal, Leen, Ann M.
Publicado 2020

44. Impact of Nursing Home (NH) Universal Decolonization and COVID Prevention Training on COVID-19 Burden During the 2020-2021 Winter Surge in Orange County (OC), California (CA)

por Gussin, Gabrielle, Singh, Raveena, Gohil, Shruti K, Saavedra, Raheeb, Tjoa, Thomas, Pedroza, Robert, Berman, Chase, Park, Jessica, Ghasemian, Kimia, Osalvo, Avy, Hsi, Joshua, Hsi, Emily A, Chun, Stephanie, Zahn, Matthew, Fonda, Emily, Huang, Susan S
Publicado 2021

571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster

por Tebas, Pablo, Agnes, Joseph, Giffear, Mary, Kraynyak, Kimberly A, Blackwood, Elliott, Amante, Dinah, Reuschel, Emma, Liu, Neiman, Purwar, Mansi, Christensen-Quick, Aaron, Andrade, Viviane M, Carter, Julie, Garufi, Gabriella, Diehl, Malissa, Sylvester, Albert, Morrow, Matthew P, Pezzoli, Patrick P, Kulkarni, Abhijeet J, Zaidi, Faraz I, Frase, Drew, Liaw, Kevin, Patel, Ami, Buttigieg, Karen R, Ervin, John E, Pawlicki, Jan, Gillespie, Elisabeth, Maricic, Igor, Schultheis, Katherine, Badie, Hedieh, Herring, Timothy A, Simon, Keiko O, Smith, Trevor R F, Ramos, Stephanie, Spitz, Robert, Lee, Jessica, Dallas, Michael, Brown, Ami Shah, Shea, Jacqueline E, Kim, J Joseph, Weiner, David, Broderick, Kate, McMullan, Trevor, Boyer, Jean, Humeau, Laurent, Mammen Jr., Mammen P
Publicado 2021

LB1. Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

por Hill, Joshua A, Paredes, Roger, Vaca, Carlos, Mera, Jorge, Webb, Brandon J, Perez, Gilberto, Oguchi, Godson, Ryan, Pablo, Gerstoft, Jan, Brown, Michael, Schiffer, Joshua, Brown, Samuel, Katz, Morgan, Ginde, Adit A, Camus, Gregory, Porter, Danielle P, Hyland, Robert H, Chen, Shuguang, Juneja, Kavita, Osinusi, Anu, Duff, Frank, Gottlieb, Robert L
Publicado 2021

289. Post COVID Syndrome Cohort Characterization

por Chatwani, Bhoomija, Flaherty, Shelby, Liu, Sharon, Theberge, Marc, Zeller, Mark, Anderson, Kristian, Boisen, Matt, Branco, Luis, Garry, Robert, Drouin, Arnaud, Fusco, Dahlene
Publicado 2021

Antibody and T-Cell Responses to Covid-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL)

por Ayers, Emily C., Wilson, Jeffrey, Canderan, Glenda, Keshavarz, Behnam, Woodfolk, Judith, Portell, Craig A., Williams, Michael E.
Publicado 2021

For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation

por Haggenburg, Sabine, Lissenberg-Witte, Birgit I., Van Binnendijk, Robert S., Den Hartog, Gerco, Michel, Bhoekhan S., Haverkate, Nienke J.E., De Rooij, Dennis M., Broers, Annoek E.C., Mutsaers, Pim G.N.J., Van Meerten, Tom, van Doesum, Jaap, Kater, Arnon P., Zweegman, Sonja, Van Gils, Marit J., Goorhuis, Bram, Rutten, Caroline E., Hazenberg, Mette D., Nijhof, Inger S.
Publicado 2021

O25 Catastrophic antiphospholipid crisis triggered by anticoagulant switch

por Andev, Rajinder Singh, Dubey, Shirish, Brand, Alexander, David, Joel, Luqmani, Raashid
Publicado 2021